{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:51:37Z","timestamp":1787003497888,"version":"build-2736575974"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T00:00:00Z","timestamp":1677715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T00:00:00Z","timestamp":1677715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005774","name":"University of Barcelona","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005774","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CPII19\/00009"],"award-info":[{"award-number":["CPII19\/00009"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fomento de la Investigaci\u00f3n and European Regional Development Fund"},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Biomedical Research Centre initiative"},{"DOI":"10.13039\/501100007747","name":"Red Espa\u00f1ola de Esclerosis M\u00faltiple","doi-asserted-by":"publisher","award":["RD16\/0015\/0002, RD16\/0015\/0003, RD12\/0032\/0002, RD12\/0060\/01-02"],"award-info":[{"award-number":["RD16\/0015\/0002, RD16\/0015\/0003, RD12\/0032\/0002, RD12\/0060\/01-02"]}],"id":[{"id":"10.13039\/501100007747","id-type":"DOI","asserted-by":"publisher"}]},{"name":"TEVA Spain"},{"name":"Fundaci\u00f3n Merck Salud, Spain"},{"name":"Proyecto Societat Catalana Neurologia"},{"name":"Instituto Carlos III (ISCIII) and co-funded by the European Union","award":["PI15\/00587, PI18\/01030, PI21\/01189, PI15\/00061, JR16\/00006, MV17\/00021, PI17\/01228, RD16\/0015\/0003"],"award-info":[{"award-number":["PI15\/00587, PI18\/01030, PI21\/01189, PI15\/00061, JR16\/00006, MV17\/00021, PI17\/01228, RD16\/0015\/0003"]}]},{"name":"ECTRIMS Clinical Training Fellowship Programme"},{"name":"MS Innovation GMSI"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The relationship between brain diffusion microstructural changes and disability in multiple sclerosis (MS) remains poorly understood. We aimed to explore the predictive value of microstructural properties in white (WM) and grey matter (GM), and identify areas associated with mid-term disability in MS patients. We studied 185 patients (71% female; 86% RRMS) with the Expanded Disability Status Scale (EDSS), timed 25-foot walk (T25FW), nine-hole peg test (9HPT), and Symbol Digit Modalities Test (SDMT) at two time-points. We used Lasso regression to analyse the predictive value of baseline WM fractional anisotropy and GM mean diffusivity, and to identify areas related to each outcome at 4.1\u00a0years follow-up. Motor performance was associated with WM (T25FW: RMSE\u2009=\u20090.524, R\n                    <jats:sup>2<\/jats:sup>\n                    \u2009=\u20090.304; 9HPT dominant hand: RMSE\u2009=\u20090.662, R\n                    <jats:sup>2<\/jats:sup>\n                    \u2009=\u20090.062; 9HPT non-dominant hand: RMSE\u2009=\u20090.649, R\n                    <jats:sup>2<\/jats:sup>\n                    \u2009=\u20090.139), and SDMT with GM diffusion metrics (RMSE\u2009=\u20090.772, R\n                    <jats:sup>2<\/jats:sup>\n                    \u2009=\u20090.186). Cingulum, longitudinal fasciculus, optic radiation, forceps minor and frontal aslant were the WM tracts most closely linked to motor dysfunction, and temporal and frontal cortex were relevant for cognition. Regional specificity related to clinical outcomes provide valuable information that can be used to develop more accurate predictive models that could improve therapeutic strategies.\n                  <\/jats:p>","DOI":"10.1038\/s41598-023-30502-5","type":"journal-article","created":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T10:02:58Z","timestamp":1677751378000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Diffusion tensor imaging metrics associated with future disability in multiple sclerosis"],"prefix":"10.1038","volume":"13","author":[{"given":"E.","family":"Lopez-Soley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Martinez-Heras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Solana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Solanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Radua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Vivo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Prados","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sepulveda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. M.","family":"Cabrera-Maqueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Alba-Arbalat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. H.","family":"Martinez-Lapiscina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Villoslada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Saiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Llufriu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,2]]},"reference":[{"key":"30502_CR1","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/S1474-4422(14)70250-9","volume":"14","author":"MA Rocca","year":"2015","unstructured":"Rocca, M. A. et al. Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis. Lancet Neurol. 14, 302\u2013317 (2015).","journal-title":"Lancet Neurol."},{"key":"30502_CR2","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nrneurol.2015.157","volume":"11","author":"MP Wattjes","year":"2015","unstructured":"Wattjes, M. P. et al. Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis\u2013establishing disease prognosis and monitoring patients. Nat. Rev. Neurol. 11, 597\u2013606 (2015).","journal-title":"Nat. Rev. Neurol."},{"key":"30502_CR3","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/nbm.1515","volume":"23","author":"M Inglese","year":"2010","unstructured":"Inglese, M. & Bester, M. Diffusion imaging in multiple sclerosis: Research and clinical implications. NMR Biomed. 23, 865\u2013872 (2010).","journal-title":"NMR Biomed."},{"key":"30502_CR4","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1177\/1352458520958356","volume":"27","author":"C Cordani","year":"2021","unstructured":"Cordani, C. et al. MRI correlates of clinical disability and hand-motor performance in multiple sclerosis phenotypes. Mult. Scler. 27, 1205\u20131221 (2021).","journal-title":"Mult. Scler."},{"key":"30502_CR5","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.nicl.2017.09.019","volume":"17","author":"DS Peterson","year":"2018","unstructured":"Peterson, D. S. & Fling, B. W. How changes in brain activity and connectivity are associated with motor performance in people with MS. Neuroimage Clin. 17, 153\u2013162 (2018).","journal-title":"Neuroimage Clin."},{"key":"30502_CR6","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1212\/WNL.0b013e31828726cc","volume":"80","author":"HE Hulst","year":"2013","unstructured":"Hulst, H. E. et al. Cognitive impairment in MS: Impact of white matter integrity, gray matter volume, and lesions. Neurology 80, 1025\u20131032 (2013).","journal-title":"Neurology"},{"key":"30502_CR7","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.nicl.2016.11.026","volume":"13","author":"S Llufriu","year":"2017","unstructured":"Llufriu, S. et al. Structural networks involved in attention and executive functions in multiple sclerosis. Neuroimage Clin. 13, 288\u2013296 (2017).","journal-title":"Neuroimage Clin."},{"key":"30502_CR8","doi-asserted-by":"publisher","first-page":"16805","DOI":"10.1038\/s41598-021-96132-x","volume":"11","author":"E Solana","year":"2021","unstructured":"Solana, E. et al. Regional grey matter microstructural changes and volume loss according to disease duration in multiple sclerosis patients. Sci. Rep. 11, 16805 (2021).","journal-title":"Sci. Rep."},{"key":"30502_CR9","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3389\/fphys.2020.00116","volume":"11","author":"B Stock","year":"2020","unstructured":"Stock, B. et al. Distribution of cortical diffusion tensor imaging changes in multiple sclerosis. Front. Physiol. 11, 116 (2020).","journal-title":"Front. Physiol."},{"key":"30502_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1194","volume":"9","author":"M Kolasa","year":"2019","unstructured":"Kolasa, M. et al. Diffusion tensor imaging and disability progression in multiple sclerosis: A 4-year follow-up study. Brain Behav. 9, e01194 (2019).","journal-title":"Brain Behav."},{"key":"30502_CR11","first-page":"2605","volume":"141","author":"AJC Eijlers","year":"2018","unstructured":"Eijlers, A. J. C. et al. Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study. Brain 141, 2605\u20132618 (2018).","journal-title":"Brain"},{"key":"30502_CR12","doi-asserted-by":"publisher","first-page":"4834","DOI":"10.1007\/s00415-021-10605-7","volume":"268","author":"S Tommasin","year":"2021","unstructured":"Tommasin, S. et al. Machine learning classifier to identify clinical and radiological features relevant to disability progression in multiple sclerosis. J. Neurol. 268, 4834\u20134845 (2021).","journal-title":"J. Neurol."},{"key":"30502_CR13","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1177\/1352458513503722","volume":"20","author":"S Llufriu","year":"2014","unstructured":"Llufriu, S. et al. Cognitive functions in multiple sclerosis: Impact of gray matter integrity. Mult. Scler. 20, 424\u2013432 (2014).","journal-title":"Mult. Scler."},{"key":"30502_CR14","doi-asserted-by":"publisher","first-page":"3749","DOI":"10.1111\/ene.15023","volume":"28","author":"L Conti","year":"2021","unstructured":"Conti, L. et al. Unraveling the substrates of cognitive impairment in multiple sclerosis: A multiparametric structural and functional magnetic resonance imaging study. Eur. J. Neurol. 28, 3749\u20133759 (2021).","journal-title":"Eur. J. Neurol."},{"key":"30502_CR15","doi-asserted-by":"crossref","unstructured":"Seccia, R. et al. Machine learning use for prognostic purposes in multiple sclerosis. Life 11, (2021).","DOI":"10.3390\/life11020122"},{"key":"30502_CR16","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1002\/hbm.21125","volume":"32","author":"G Riccitelli","year":"2011","unstructured":"Riccitelli, G. et al. Cognitive impairment in multiple sclerosis is associated to different patterns of gray matter atrophy according to clinical phenotype. Hum. Brain Mapp. 32, 1535\u20131543 (2011).","journal-title":"Hum. Brain Mapp."},{"key":"30502_CR17","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/brain\/awn275","volume":"132","author":"RA Dineen","year":"2009","unstructured":"Dineen, R. A. et al. Disconnection as a mechanism for cognitive dysfunction in multiple sclerosis. Brain 132, 239\u2013249 (2009).","journal-title":"Brain"},{"key":"30502_CR18","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1177\/1352458516676642","volume":"23","author":"I Gabilondo","year":"2017","unstructured":"Gabilondo, I. et al. The influence of posterior visual pathway damage on visual information processing speed in multiple sclerosis. Mult. Scler. 23, 1276\u20131288 (2017).","journal-title":"Mult. Scler."},{"key":"30502_CR19","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson, A. J. et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 17, 162\u2013173 (2018).","journal-title":"Lancet Neurol."},{"key":"30502_CR20","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1186\/1756-0500-7-910","volume":"7","author":"EH Mart\u00ednez-Lapiscina","year":"2014","unstructured":"Mart\u00ednez-Lapiscina, E. H. et al. The multiple sclerosis visual pathway cohort: Understanding neurodegeneration in MS. BMC Res. Notes 7, 910 (2014).","journal-title":"BMC Res. Notes"},{"key":"30502_CR21","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke, J. F. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 33, 1444\u20131452 (1983).","journal-title":"Neurology"},{"key":"30502_CR22","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","volume":"83","author":"FD Lublin","year":"2014","unstructured":"Lublin, F. D. et al. Defining the clinical course of multiple sclerosis: The 2013 revisions. Neurology 83, 278\u2013286 (2014).","journal-title":"Neurology"},{"key":"30502_CR23","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1177\/1352458506070768","volume":"12","author":"JJ Kragt","year":"2006","unstructured":"Kragt, J. J., van der Linden, F. A. H., Nielsen, J. M., Uitdehaag, B. M. J. & Polman, C. H. Clinical impact of 20% worsening on timed 25-foot walk and 9-hole peg test in multiple sclerosis. Mult. Scler. 12, 594\u2013598 (2006).","journal-title":"Mult. Scler."},{"key":"30502_CR24","unstructured":"Smith. Symbol digit modalities test: Manual. Los Angeles: Western Psychological Services. Tech. Rep. Navtradevcen."},{"key":"30502_CR25","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1177\/1352458517690821","volume":"23","author":"RH Benedict","year":"2017","unstructured":"Benedict, R. H. et al. Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis. Mult. Scler. 23, 721\u2013733 (2017).","journal-title":"Mult. Scler."},{"key":"30502_CR26","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1002\/hbm.21344","volume":"33","author":"M Battaglini","year":"2012","unstructured":"Battaglini, M., Jenkinson, M. & De Stefano, N. Evaluating and reducing the impact of white matter lesions on brain volume measurements. Hum. Brain Mapp. 33, 2062\u20132071 (2012).","journal-title":"Hum. Brain Mapp."},{"key":"30502_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1005350","volume":"13","author":"A Klein","year":"2017","unstructured":"Klein, A. et al. Mindboggling morphometry of human brains. PLoS Comput. Biol. 13, e1005350 (2017).","journal-title":"PLoS Comput. Biol."},{"key":"30502_CR28","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.neuroimage.2011.02.046","volume":"56","author":"B Patenaude","year":"2011","unstructured":"Patenaude, B., Smith, S. M., Kennedy, D. N. & Jenkinson, M. A Bayesian model of shape and appearance for subcortical brain segmentation. Neuroimage 56, 907\u2013922 (2011).","journal-title":"Neuroimage"},{"key":"30502_CR29","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.media.2007.06.004","volume":"12","author":"BB Avants","year":"2008","unstructured":"Avants, B. B., Epstein, C. L., Grossman, M. & Gee, J. C. Symmetric diffeomorphic image registration with cross-correlation: evaluating automated labeling of elderly and neurodegenerative brain. Med. Image Anal. 12, 26\u201341 (2008).","journal-title":"Med. Image Anal."},{"key":"30502_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2020.116923","volume":"217","author":"S Warrington","year":"2020","unstructured":"Warrington, S. et al. XTRACT\u2014Standardised protocols for automated tractography in the human and macaque brain. Neuroimage 217, 116923 (2020).","journal-title":"Neuroimage"},{"key":"30502_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2019.116137","volume":"202","author":"J-D Tournier","year":"2019","unstructured":"Tournier, J.-D. et al. MRtrix3: A fast, flexible and open software framework for medical image processing and visualisation. Neuroimage 202, 116137 (2019).","journal-title":"Neuroimage"},{"key":"30502_CR32","doi-asserted-by":"publisher","unstructured":"Jenkinson, M., Beckmann, C. F., Behrens, T. E. J., Woolrich, M. W. & Smith, S. M. FSL. NeuroImage vol. 62 782\u2013790. https:\/\/doi.org\/10.1016\/j.neuroimage.2011.09.015 (2012).","DOI":"10.1016\/j.neuroimage.2011.09.015"},{"key":"30502_CR33","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1006\/jmrb.1994.1037","volume":"103","author":"PJ Basser","year":"1994","unstructured":"Basser, P. J., Mattiello, J. & LeBihan, D. Estimation of the effective self-diffusion tensor from the NMR spin echo. J. Magn. Reson. B 103, 247\u2013254 (1994).","journal-title":"J. Magn. Reson. B"},{"key":"30502_CR34","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.neuroimage.2009.06.060","volume":"48","author":"DN Greve","year":"2009","unstructured":"Greve, D. N. & Fischl, B. Accurate and robust brain image alignment using boundary-based registration. Neuroimage 48, 63\u201372 (2009).","journal-title":"Neuroimage"},{"key":"30502_CR35","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.neuroimage.2017.11.024","volume":"167","author":"J-P Fortin","year":"2018","unstructured":"Fortin, J.-P. et al. Harmonization of cortical thickness measurements across scanners and sites. Neuroimage 167, 104\u2013120 (2018).","journal-title":"Neuroimage"},{"key":"30502_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2020.116956","volume":"218","author":"J Radua","year":"2020","unstructured":"Radua, J. et al. Increased power by harmonizing structural MRI site differences with the ComBat batch adjustment method in ENIGMA. Neuroimage 218, 116956 (2020).","journal-title":"Neuroimage"},{"key":"30502_CR37","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/ana.26370","volume":"92","author":"G Bose","year":"2022","unstructured":"Bose, G. et al. Early predictors of clinical and mri outcomes using least absolute shrinkage and selection operator (LASSO) in Multiple sclerosis. Ann. Neurol. 92, 87\u201396 (2022).","journal-title":"Ann. Neurol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-30502-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-30502-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-30502-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T10:07:09Z","timestamp":1677751629000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-30502-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,2]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["30502"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-30502-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2016685\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,2]]},"assertion":[{"value":"31 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"EM-H, AS, JR, FV, EF, SA-A have nothing to disclose; EL-S and ES received travel reimbursement from Sanofi and ECTRIMS; FP received a Guarantors of Brain fellowship 2017\u20132020; MS received speaker honoraria from Genzyme, Novartis and Biogen; JMC-M received speaker honoraria from Sanfi; Y.B. received speaking honoraria from Biogen, Novartis and Genzyme; EHM-L received travel support for international and national meetings from Roche and Sanofi-Genzyme, and honoraria for consultancies from Novartis, Roche and Sanofi before joining the European Medicines Agency, where she is currently employed (Human Medicines, since 16 April 2019); however, her contribution to this article is related to her activity at the Hospital Clinic Barcelona\/IDIBAPS and therefore does not represent the views of the Agency or its Committees. She is a member of the International Multiple Sclerosis Visual System (IMSVISUAL) Consortium; PV is a shareholder and has received consultancy fees from Accure Therapeutics SL, Attune Neurosciences Inc, QMenta Inc, Spiral Therapeutix Inc, CLight Inc and NeuroPrex Inc, as well as having held grants from the Instituto de Salud Carlos III and the European Commissions; AS received consulting fees and speaker honoraria from Bayer-Schering, Merck-Serono, Biogen-Idec, Sanofi-Aventis, TEVA, Novartis and Roche, Janssen and Horizon Therapeutics; SL received consulting fees and speaker honoraria from Biogen Idec, Novartis, TEVA, Genzyme, Sanofi and Merck.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3565"}}